CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesAimin Jiang, Linhui Wang, Ye Zhou et al.|Oxidative Medicine and Cellular Longevity|2022Cited by 65
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell CarcinomaAimin Jiang, Chen Cai, Juelan Ye et al.|Cells|2023Cited by 34
Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort studyLe Qu, Ming Chen, Hui Chen et al.|MedComm|2023Cited by 8
Development and validation of a prognostic model predicting the prognosis of surgically treated non-clear cell renal cell carcinoma patients with tumor thrombusHe Miao, Le Qu, Ye Zhou et al.|Research Square|2024Cited by 0